A Phase 2, Multicenter,Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Risankizumab inAdult Subjects with Moderate to Severe Hidradenitis Suppurativa

Project: Research project

Project Details

Description

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Risankizumab in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa
StatusActive
Effective start/end date8/8/198/30/24

Funding

  • ABBVIE INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.